Article Text

Download PDFPDF
First diabetic retinopathy prevalence study in Portugal: RETINODIAB Study—Evaluation of the screening programme for Lisbon and Tagus Valley region
  1. Marco Dutra Medeiros1,2,3,
  2. Edgar Mesquita4,
  3. Ana Luísa Papoila5,6,7,
  4. Victor Genro1,
  5. João Filipe Raposo1,8
  1. 1Portuguese Diabetes Association APDP, Lisbon, Portugal
  2. 2Department of Ophthalmology, Central Lisbon Hospital Center, Lisbon, Portugal
  3. 3NOVA Medical School, Universidade NOVA de Lisboa, Lisbon, Portugal
  4. 4University of Minho, Braga, Portugal
  5. 5CEAUL, Lisbon, Portugal
  6. 6Statistics and Informatics Department, NOVA Medical School, Universidade NOVA de Lisboa, Lisbon, Portugal
  7. 7Epidemiology and Statistics Unit, Research Centre, Central Lisbon Hospital Center, Lisbon, Portugal
  8. 8Department of Public Health/CEDOC, NOVA Medical School, Universidade NOVA de Lisboa, Lisbon, Portugal
  1. Correspondence to Dr Marco Dutra Medeiros, Portuguese Diabetes Association (APDP), Rua Salitre 118, Lisbon 1250-203, Portugal; marcodutramedeiros{at}


Background/aims In Portugal, so far, there is no study or even accurate data on the prevalence of diabetic retinopathy (DR), based on a large representative sample and on a long-term follow-up. The objective of our study was to determine the prevalence of DR based on a national screening community-based programme.

Methods A 5-year retrospective analysis of the RETINODIAB screening programme results was implemented in Lisbon and Tagus Valley area between July 2009 and October 2014. We estimated the prevalence of retinopathy for all patients with type 2 diabetes and studied the association between known risk factors and retinopathy emergence at their first screening.

Results Throughout this period, from a total of 103 102 DR readable screening examinations, 52 739 corresponded to patients who attended RETINODIAB screening at entry. Globally, DR was detected in 8584 patients (16.3%). Of these, 5484 patients (10.4%) had mild non-proliferative (NP) DR, 1457 patients (2.8%) had moderate NPDR and 672 (1.3%) had severe NPDR. Finally, 971 patients (1.8%) had proliferative DR requiring urgent referral to an ophthalmologist. The presence of any DR, non-referable DR or referable DR was strongly associated with increasing duration of diabetes and earlier age at diagnosis.

Conclusions The prevalence rate of DR in our study (16.3%) was slightly lower than other published international data. The RETINODIAB network proved to be an effective screening programme as it improved DR screening in Lisbon and Tagus Valley surrounding area.

  • Epidemiology
  • Macula
  • Retina
  • Clinical Trial
  • Treatment Lasers

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Linked Articles

  • At a glance
    Keith Barton James Chodosh Jost Jonas